Loading clinical trials...
Loading clinical trials...
This study investigates the effects of Splenda, an artificial sweetener powder containing sucralose, on post-prandial blood glucose levels, appetite scores and subsequent energy intake.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
King's College London
NCT05543083 · Insulin Resistance, Depression, and more
NCT06575426 · Diabetes Mellitus, Type 1, Hypoglycemia, and more
NCT06105164 · Appetitive Behavior, Obesity
NCT06508424 · Glycaemic Response, Appetitive Behavior, and more
NCT06327087 · Appetitive Behavior, Healthy, and more
King's College London
London
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions